Predicting selective drug targets in cancer through metabolic networks.
about
The evolution of genome-scale models of cancer metabolismGenome-scale screening of drug-target associations relevant to Ki using a chemogenomics approachStable isotope-resolved metabolomics and applications for drug developmentPathway Analysis: State of the ArtCancer Metabolism: A Modeling PerspectiveBlood transcriptomics and metabolomics for personalized medicineBig Data Analytics in Healthcare.Software applications for flux balance analysisComputational approaches for understanding energy metabolismA survey on the computational approaches to identify drug targets in the postgenomic eraStructure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive reviewMetabolomics and systems pharmacology: why and how to model the human metabolic network for drug discoveryUsing drug response data to identify molecular effectors, and molecular "omic" data to identify candidate drugs in cancerReconstruction of Tissue-Specific Metabolic Networks Using CORDATargeting pathogen metabolism without collateral damage to the hostPrediction of drug-target interactions and drug repositioning via network-based inferenceReconstruction of genome-scale active metabolic networks for 69 human cell types and 16 cancer types using INITComparative evaluation of open source software for mapping between metabolite identifiers in metabolic network reconstructions: application to Recon 2Target inhibition networks: predicting selective combinations of druggable targets to block cancer survival pathwaysControllability in cancer metabolic networks according to drug targets as driver nodesA network inference method for large-scale unsupervised identification of novel drug-drug interactionsFast reconstruction of compact context-specific metabolic network modelsLeveraging systems biology approaches in clinical pharmacologyComparative genome-scale reconstruction of gapless metabolic networks for present and ancestral speciesIntegrating transcriptomics with metabolic modeling predicts biomarkers and drug targets for Alzheimer's diseaseAssessment of FBA Based Gene Essentiality Analysis in Cancer with a Fast Context-Specific Network Reconstruction MethodIntegrated metabolic modelling reveals cell-type specific epigenetic control points of the macrophage metabolic networkIntegrated network analysis and effective tools in plant systems biology.A community-driven global reconstruction of human metabolism.Reconciled rat and human metabolic networks for comparative toxicogenomics and biomarker predictions.Mechanistic systems modeling to guide drug discovery and developmentGenome-level transcription data of Yersinia pestis analyzed with a new metabolic constraint-based approach.Investigation on metabolism of cisplatin resistant ovarian cancer using a genome scale metabolic model and microarray dataPrediction of intracellular metabolic states from extracellular metabolomic dataAn NGS Workflow Blueprint for DNA Sequencing Data and Its Application in Individualized Molecular Oncology.Integrative analysis of human omics data using biomolecular networks.Data-Driven Metabolic Pathway Compositions Enhance Cancer Survival Prediction.Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling.High-resolution network biology: connecting sequence with function.Systematic discovery of mutation-specific synthetic lethals by mining pan-cancer human primary tumor data.
P2860
Q21129241-F9329C97-2156-4958-8B89-9C6A749290B8Q21133651-4F6059CA-AF1D-4903-AD79-99EDF7E19D41Q24629149-F9843FDE-739A-4C50-96BE-E54E21E2CE2CQ26770725-E29AD3CB-9CE1-4A7F-B922-F1A0B22C0AE4Q26770819-8D6570A0-D9F8-4830-9059-99FCA58AF93DQ26772073-97BA5DCE-EF98-4B26-8F52-8AEEF8CD187AQ26800999-98F7A5F1-2628-4DFB-82BB-A82122FBC107Q26824185-5B03724D-F626-47C1-BC74-98F4DF3B6FA3Q26859964-B4888B44-5C9E-40A2-B0C6-7EC6067AB76AQ27003870-4DEB661B-5370-472F-812D-C0F65B4271B8Q27008867-B0A69505-9388-465A-9A28-C7D025CE728FQ27144251-BA9DB9EB-6F60-4B83-A25E-C902773CE6CBQ27320602-7E223877-8BF4-425C-B4AC-8BDA2571A700Q28388815-A8137036-2324-48F5-BCA3-238A60E21A2BQ28468608-E0FC7606-982E-491E-8CC7-6F40B65759B4Q28483634-2D3ADC23-FC7C-4955-BEA3-D0C0367EF487Q28483779-099FB5BE-17B0-4165-BE86-FD2A3FCFDAD5Q28487717-92628BD9-12BD-4ECA-BFD5-8B4FC242542EQ28533401-7AF183C6-4A9C-49EC-B7C9-8BCDE2B4A6A1Q28535399-D9B17A2B-418B-4EEB-87F1-175F3F4C8892Q28536026-EE4675E0-99A1-4AEF-AD75-418F6BAB67DFQ28538763-D2E3907F-BF5B-43D1-8916-B8383DBB7896Q28539118-195ED182-65A4-4BB3-A95F-80FB268A3973Q28539590-31CA59EC-699E-43CB-8CD6-1767703AD86DQ28542022-2E67D4C1-05A3-44A5-B465-59F6EFAC6A29Q28551811-B983F533-6274-4B5B-96FE-597B40355A9EQ28608553-53953EEC-C263-49AA-86CA-25B725A77097Q28652732-7C4F4860-E94A-47A3-9EF3-5C9138DF5A07Q29614690-37359B32-50D4-4877-A847-C092B398FDC1Q30274820-4F6061E1-D702-49C6-A7CD-FD75B4663B23Q30414988-41FCB0E4-5AAE-48BC-A32D-934832BA05E4Q30580389-5B0D0B9B-82C8-4427-8D99-1C3FF1C2F64FQ30945278-85B81A1D-EC22-4360-A1C4-5AB2A3CAD21AQ30951388-5E83358C-729A-40E6-BA0B-9A1A182613BDQ31077769-9ACA1152-A5EE-4B34-BCDF-0E69528BB84EQ31120979-EAE5737A-14A9-4DA2-BE8E-E48BAA9FB946Q31133387-E8F660D0-3843-4E98-9C00-652E4419FE26Q33597307-D682B781-F361-4E68-8B51-C11E85679F6EQ33623110-27804D9D-BE03-46F2-B7DF-0AB868EFE014Q33766729-60ABF9BA-9525-423A-89F6-C207144C4EFA
P2860
Predicting selective drug targets in cancer through metabolic networks.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Predicting selective drug targets in cancer through metabolic networks.
@ast
Predicting selective drug targets in cancer through metabolic networks.
@en
type
label
Predicting selective drug targets in cancer through metabolic networks.
@ast
Predicting selective drug targets in cancer through metabolic networks.
@en
prefLabel
Predicting selective drug targets in cancer through metabolic networks.
@ast
Predicting selective drug targets in cancer through metabolic networks.
@en
P2093
P2860
P50
P356
P1476
Predicting selective drug targets in cancer through metabolic networks.
@en
P2093
Livnat Jerby
Ori Folger
Tomer Shlomi
P2860
P356
10.1038/MSB.2011.35
P577
2011-06-21T00:00:00Z